SynthesisBreast cancer research : BCR2015

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer--a systematic review.

Diogo Mendes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.